Zobrazeno 1 - 9
of 9
pro vyhledávání: '"David J. Kuntz"'
Autor:
Ruth E. Winecker, Elia Goffi, George E. Bigelow, Ryan Vandrey, John M. Mitchell, Ronald Flegel, Edward J. Cone, David J. Kuntz, Tory R. Spindle, Dennis J. Sholler
Publikováno v:
J Anal Toxicol
The market for products containing cannabidiol (CBD) is booming globally. However, the pharmacokinetics of CBD in different oral formulations and the impact of CBD use on urine drug testing outcomes for cannabis (e.g., 11-nor-9-carboxy-Δ9-tetrahydro
Autor:
Svante Vikingsson, Ruth E Winecker, Edward J Cone, David J Kuntz, Brian Dorsey, Martin Jacques, Melanie Senter, Ronald R Flegel, Eugene D Hayes
Publikováno v:
Journal of analytical toxicology. 46(8)
Given the recent popularity of cannabidiol (CBD) use and the emergence of ∆8-tetrahydrocannabinol (∆8-THC), the prevalence and concentrations of these and other cannabinoids were investigated in 2,000 regulated and 4,000 non-regulated specimens f
Autor:
George E. Bigelow, Ryan Vandrey, John M. Mitchell, Ronald Flegel, Edward J. Cone, David J. Kuntz, Tory R. Spindle
Publikováno v:
J Anal Toxicol
Cannabis products in which cannabidiol (CBD) is the primary chemical constituent (CBD-dominant) are increasingly popular and widely available. The impact of CBD exposure on urine drug testing has not been well studied. This study characterized the ur
Autor:
Patrick S. Cardona, Albert D. Fraser, Kristi J. Craft, Arvind K. Chaturvedi, Jonelle E. Wright, Kurt M. Dubowski, Jim L. Sershon, Dennis V. Canfield, Misti J. Leyva, Steve M. Blevins, Christopher E. Aston, James E. Whinnery, John W. Soper, David J. Kuntz
Publikováno v:
Journal of Analytical Toxicology. 37:5-10
During workplace drug testing, urine is tested for dilution, substitution and adulteration. Donors argue that these findings are due to medical, health or working conditions or diet and genetic differences. There is a paucity of data correlating chan
Publikováno v:
Toxicology and Applied Pharmacology. 103:40-51
A high dose (550 mg/kg) of 3-methylindole (3MI) specifically damaged pulmonary tissue in Swiss-Webster mice without causing any hepatic or renal necrosis. When a glutathione depleter, L-buthionine-(S,R)-sulfoximine (BSO, 1.0 mmol/kg), was administere
Publikováno v:
Journal of applied toxicology : JAT. 11(4)
The effects of mixtures of parathion (PA; 5 mg kg−1), toxaphene (TOX; 50 mg kg−1) and/or 2,4-dichlorophenoxyacetic acid (2,4-D; 50 mg kg−1) on the hepatic mixed-function oxygenase (MFO) system were studied in ICR male mice (21–24 g) by oral i
Publikováno v:
Journal of applied toxicology : JAT. 10(4)
The toxicity of the mixtures of parathion (PA), toxaphene (TOX) and/or 2,4-dichlorophenoxyacetic acid (2,4-D) was studied in ICR male mice (21–24 g) by oral intubation, in corn oil, daily for up to 14 days. On Day 15, the exposure was discontinued,
Autor:
Dennis J. Crouch, David M. Andrenyak, Matthew L. Cheever, David J. Kuntz, David L. Loughmiller
Publikováno v:
Journal of Forensic Sciences. 43:16086J
This study was designed to compare results obtained from two separate on-site drug testing kits (ONTRAK TESTCUP and Abuscreen ONTRAK) with those obtained from laboratory based immunoassay and GC/MS. Abuscreen ONLINE immunoassay was used to select 250
Autor:
Arvind K. Chaturvedi, David J. Kuntz
Publikováno v:
Pharmacology Biochemistry and Behavior. 30:1035-1043
The interaction between phencyclidine (PCP) and its pyrolysis product, 1-phenylcyclohexene (PC), at metabolic level was evaluated in Swiss male mice (21-24 g). PC (1.1, 2.2 and 4.4 mmol/kg/day for 4 days, IP, in corn oil) treatment to mice induced th